Suber S. Huang, MD, MBA, will serve as Digital's Medical Director for
WAKE FOREST, N.C., Nov. 15 /PRNewswire/ -- Digital Healthcare, a Wake Forest, NC company specializing in retinal risk assessment for diabetics, announced today that Suber S. Huang, MD, MBA has been named Medical Director for Ophthalmology. Dr. Huang will provide the company expert advice and counsel regarding product development and development.
Dr. Huang is the Philip F. and Elizabeth G. Searle-Suber Huang, MD, Professor and Vice Chairman in the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center, Cleveland, Ohio. He is the Director of Vitreoretinal Diseases and Surgery, the Director of Clinical Research, and the Director of the Retinal Diseases Image Analysis Reading Center (REDIARC). Dr. Huang serves on the Executive Board of Directors for the American Society of Retina Specialists, the world's largest organization of retinal specialists. Dr. Huang is the Director of the Diabetic Eye Disease Committee of the National Eye Health Education Program and the serves on the Ophthalmic Technology Assessment Committee (OTAC)-Retina/Vitreous Panel and on the Research, Regulatory, and External Scientific Relations Committee, both committees associated with the American Academy of Ophthalmology.
"Having one of the country's premier retinal specialists on our team will be invaluable," said Marc Winchester, President, North America and Board Director of Digital Healthcare. "Retasure is focused on retinal health and, we will rely on Dr. Huang's vast medical expertise to advise us on future product enhancements. With Dr. Huang's input, Retasure will continue to be the industry's leading retinal risk assessment tool."
"Retasure is a terrific system that provides benefits for patients at risk for diabetic retinopathy," said Dr. Huang. "Earlier detection of patients with diabetic eye disease by endocrinologists and primary care physicians will mean earlier referral to an ophthalmologist. Early diagnosis and treatment of complications is critical to reduce the chance of permanent visual loss. As a retinal specialist and advocate, I am excited about promoting and enhancing a service that benefits our whole health system."
The FDA-approved Retasure program provides a simple, affordable, and non- invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure, HIPPA compliant network to an accredited reading center. A state-licensed and board certified ophthalmologist reviews the images and results are returned to the original physician within 72 hours.
There are an estimated 20 million diabetic patients in the US, but only about half have any retinal assessments, despite a high risk of diabetic retinopathy. The National Eye Institute indicates diabetic retinopathy is the leading cause of blindness among working age American adults. More than a million patients around the world have received a retinal risk assessment using Digital Healthcare software.
About Digital Healthcare
Digital Healthcare is the global leader in retinal risk assessment. They are the world's leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including University Hospitals Case Medical Center at Case Western Reserve University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military. Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to the ordering physicians; and it encourages patient compliance for retinal evaluation and comprehensive eye examinations.
|SOURCE Digital Healthcare Inc.|
Copyright©2007 PR Newswire.
All rights reserved